![Dolutegravir plus lamivudine maintains HIV-1 suppression through week 48 in a pilot randomized trial (ASPIRE) Dolutegravir plus lamivudine maintains HIV-1 suppression through week 48 in a pilot randomized trial (ASPIRE)](https://www.natap.org/2017/images/110817/110817-5/1108171.gif)
Dolutegravir plus lamivudine maintains HIV-1 suppression through week 48 in a pilot randomized trial (ASPIRE)
![Design of the randomized, open-label, multicenter, phase III ASPIRE... | Download Scientific Diagram Design of the randomized, open-label, multicenter, phase III ASPIRE... | Download Scientific Diagram](https://www.researchgate.net/publication/330147847/figure/fig1/AS:711526398836736@1546652521315/Design-of-the-randomized-open-label-multicenter-phase-III-ASPIRE-trial-KRd-vs-Rd.png)
Design of the randomized, open-label, multicenter, phase III ASPIRE... | Download Scientific Diagram
![Acer Aspire 3 A315-510P NX.KDHSI.002 Intel Core i3-N305 8GB LPDDR5 Memory 256GB PCIe NVMe SSD Intel® UHD Graphics N 15.6″ FHD Acer ComfyView LED LCD Office (Trial) Pure Silver - Ombase Group Acer Aspire 3 A315-510P NX.KDHSI.002 Intel Core i3-N305 8GB LPDDR5 Memory 256GB PCIe NVMe SSD Intel® UHD Graphics N 15.6″ FHD Acer ComfyView LED LCD Office (Trial) Pure Silver - Ombase Group](https://ombasegroup.com/wp-content/uploads/2023/05/Acer-Aspire-3.png)
Acer Aspire 3 A315-510P NX.KDHSI.002 Intel Core i3-N305 8GB LPDDR5 Memory 256GB PCIe NVMe SSD Intel® UHD Graphics N 15.6″ FHD Acer ComfyView LED LCD Office (Trial) Pure Silver - Ombase Group
![Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment | Blood Cancer Journal Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbcj.2017.31/MediaObjects/41408_2017_Article_BFbcj201731_Fig1_HTML.jpg)
Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment | Blood Cancer Journal
![PDF) ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis PDF) ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis](https://i1.rgstatic.net/publication/345943346_ASPIRE_trial_study_protocol_for_a_double-blind_randomised_controlled_trial_of_aspirin_for_overheating_during_exercise_in_multiple_sclerosis/links/60194c3e299bf1b33e40bbbb/largepreview.png)
PDF) ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis
![The ASPIRE Trial: TMC435 in treatment-experienced patients with genotype 1 HCV infection who have failed previous PegIFN/RBV treatment: Week 24 interim analysis The ASPIRE Trial: TMC435 in treatment-experienced patients with genotype 1 HCV infection who have failed previous PegIFN/RBV treatment: Week 24 interim analysis](https://www.natap.org/2011/images/040111/methods.gif)
The ASPIRE Trial: TMC435 in treatment-experienced patients with genotype 1 HCV infection who have failed previous PegIFN/RBV treatment: Week 24 interim analysis
![UNITY Biotechnology Begins Phase 2 ASPIRE Trial Administering UBX1325 to Initial Participants with Diabetic Macular Edema UNITY Biotechnology Begins Phase 2 ASPIRE Trial Administering UBX1325 to Initial Participants with Diabetic Macular Edema](https://synapse-static.patsnap.com/strapi-static/image_e673964034.png)